Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.35 (
matrix metalloproteinase 9
)
2,207
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Brain-derived neurotrophic factor
(
BDNF
) plays a pivotal role in the regulation of the transcription of genes that encode proplasticity proteins. In the present study, we provide evidence that stimulation of rat primary cortical neurons with
BDNF
upregulates
matrix metalloproteinase 9
(
MMP-9
) mRNA and protein levels and increases enzymatic activity. The
BDNF
-induced
MMP-9
transcription was dependent on extracellular signal-regulated kinase 1/2 (ERK1/2) pathway and c-Fos expression. Overexpression of AP-1 dimers in neurons led to
MMP-9
promoter activation, with the most potent being those that contained c-Fos, whereas knockdown of endogenous c-Fos by small hairpin RNA (shRNA) reduced
BDNF
-mediated
MMP-9
transcription. Additionally, mutation of the proximal AP-1 binding site in the
MMP-9
promoter inhibited the activation of
MMP-9
transcription.
BDNF
stimulation of neurons induced binding of endogenous c-Fos to the proximal
MMP-9
promoter region. Furthermore, as the c-Fos gene is a known target of serum response factor (SRF), we investigated whether SRF contributes to
MMP-9
transcription. Inhibition of SRF and its cofactors by either overexpression of dominant negative mutants or shRNA decreased
MMP-9
promoter activation. In contrast,
MMP-9
transcription was not dependent on CREB activity. Finally, we showed that neuronal activity stimulates
MMP-9
transcription in a tyrosine kinase receptor B (TrkB)-dependent manner.
...
PMID:Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway. 2350 11